Health conditions
Prevalence of disease, disorder, injury or trauma or other health-related states.
Indicators in this framework
- National Healthcare Agreement: P04-Incidence of selected cancers, 2010
Health, Superseded 08/06/2011 - National Healthcare Agreement: P03-Incidence of end-stage kidney disease, 2010
Health, Superseded 08/06/2011 - National Healthcare Agreement: P63-Children's hearing loss, 2010
Health, Superseded 08/06/2011 - National Healthcare Agreement: P01-Proportion of babies born with low birth weight, 2010
Health, Superseded 08/06/2011 - National Healthcare Agreement: PB 01-Reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) within 15 years (Baseline specification), 2011
Health, Superseded 30/10/2011 - National Healthcare Agreement: P02-Incidence of sexually transmitted infections and blood-borne viruses, 2010
Health, Superseded 08/06/2011 - National Healthcare Agreement: PI 02-Incidence of sexually transmissible infections and blood-borne viruses, 2011
Health, Superseded 30/10/2011 - National Healthcare Agreement: PI 03-Incidence of end-stage kidney disease, 2011
Health, Superseded 30/10/2011 - National Healthcare Agreement: PI 04-Incidence of selected cancers, 2011
Health, Superseded 30/10/2011 - National Healthcare Agreement: PB 01-Reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) within 15 years (Baseline specification), 2012
Health, Superseded 25/06/2013 - National Healthcare Agreement: PI 63-Children's hearing loss, 2012
Health, Retired 25/06/2013 - National Healthcare Agreement: PI 02-Incidence of sexually transmissible infections and blood-borne viruses, 2012
Health, Retired 25/06/2013 - National Healthcare Agreement: PI 03-Incidence of end-stage kidney disease, 2012
Health, Retired 25/06/2013 - National Healthcare Agreement: PI 04-Incidence of selected cancers, 2012
Health, Superseded 25/06/2013 - National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2013
Health, Superseded 30/04/2014 - National Healthcare Agreement: PI 02-Incidence of selected cancers, 2013
Health, Superseded 30/04/2014 - National Healthcare Agreement: PI 02-Incidence of selected cancers, 2014
Health, Superseded 14/01/2015 - National Healthcare Agreement: PI 02-Incidence of selected cancers, 2015
Health, Superseded 08/07/2016 - National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2015
Health, Superseded 08/07/2016 - National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2014
Health, Superseded 14/01/2015 - National Healthcare Agreement: PI 63-Children's hearing loss, 2011
Health, Superseded 31/10/2011 - National Healthcare Agreement: PI 02–Incidence of selected cancers, 2016
Health, Superseded 31/01/2017 - National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2016
Health, Superseded 31/01/2017 - National Healthcare Agreement: PI 02–Incidence of selected cancers, 2017
Health, Superseded 30/01/2018 - National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2017
Health, Superseded 30/01/2018 - National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2018
Health, Superseded 19/06/2019 - National Healthcare Agreement: PI 02–Incidence of selected cancers, 2018
Health, Superseded 19/06/2019 - National Healthcare Agreement: PI 02–Incidence of selected cancers, 2019
Health, Superseded 13/03/2020 - National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2019
Health, Superseded 13/03/2020 - National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2020
Health, Standard 13/03/2020 - National Healthcare Agreement: PI 02–Incidence of selected cancers, 2020
Health, Standard 13/03/2020 - National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2021
Health, Standard 03/07/2020 - National Healthcare Agreement: PI 02–Incidence of selected cancers, 2021
Health, Standard 16/09/2020 - National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2022
Health, Standard 24/09/2021 - National Healthcare Agreement: PI 02–Incidence of selected cancers, 2022
Health, Standard 24/09/2021